{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:59:44Z","timestamp":1794542384219,"version":"4.9.1"},"reference-count":15,"publisher":"Elsevier","isbn-type":[{"value":"9780443431906","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.pmbts.2026.01.029","type":"book-chapter","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T12:45:17Z","timestamp":1770641117000},"page":"405-416","source":"Crossref","is-referenced-by-count":10,"title":["Live biotherapeutics in the clinic: Regulatory pathways, market dynamics, and future trends"],"prefix":"10.1016","author":[{"given":"Bhabatosh","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pmbts.2026.01.029_bib1","unstructured":"U.S. Food and Drug Administration. Early clinical trials with live biotherapeutic products: chemistry, manufacturing, and control information \u2014 guidance for industry. Silver Spring, MD: U.S. Dept of Health and Human Services, Food and Drug Administration; 2016. https:\/\/www.fda.gov\/files."},{"key":"10.1016\/bs.pmbts.2026.01.029_bib2","series-title":"Human Microbiome in Health and Disease: Part A","volume":"Vol. 191","year":"2022"},{"key":"10.1016\/bs.pmbts.2026.01.029_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-68034-3","article-title":"Antibiotic contamination and antimicrobial resistance dynamics in the urban sewage microbiome in India","author":"Paul","year":"2025","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/bs.pmbts.2026.01.029_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12038-019-9926-y","article-title":"Homeostasis and dysbiosis of the gut microbiome in health and disease","volume":"44","author":"Das","year":"2019","journal-title":"J Biosci"},{"issue":"1","key":"10.1016\/bs.pmbts.2026.01.029_bib5","first-page":"56","article-title":"Live biotherapeutic products and their regulatory framework in Italy and Europe","volume":"59","author":"Franciosa","year":"2023","journal-title":"Ann Ist Super Sanita"},{"key":"10.1016\/bs.pmbts.2026.01.029_bib6","unstructured":"FDA. REBYOTA (fecal microbiota, live\u2011jslm) approval letter and summary basis for regulatory action. U.S. FDA, November 30, 2022. U.S. Food and Drug Administration."},{"issue":"11","key":"10.1016\/bs.pmbts.2026.01.029_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.70057","article-title":"Living engineered bacterial therapeutics: emerging affordable precision interventions","volume":"17","author":"Srivastava","year":"2024","journal-title":"Microb Biotechnol"},{"key":"10.1016\/bs.pmbts.2026.01.029_bib8","unstructured":"Market size & forecasts from \u201cLive Biotherapeutics Market to Grow with a CAGR of 14.06% through 2030\u201d (TechSci Research) \u2013 USD 112.34 million in 2024 to \u223c USD 247.69 million by 2030."},{"key":"10.1016\/bs.pmbts.2026.01.029_bib9","unstructured":"4D pharma description of multiple LBP clinical programs (MRx0005, MRx0029, Blautix etc.) in development."},{"key":"10.1016\/bs.pmbts.2026.01.029_bib10","unstructured":"Regulatory GMO \/ environmental risk assessment policies in Europe for live and recombinant organisms. (EMA guidance) \u2013 implicitly from ATMP\/GMO regulatory documents. (While no specific product yet, these policies are in place)."},{"issue":"2","key":"10.1016\/bs.pmbts.2026.01.029_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41564-024-01896-3","article-title":"A decade of advances in human gut microbiome-derived biotherapeutics","volume":"10","author":"Pribyl","year":"2025","journal-title":"Nat Microbiol"},{"issue":"4","key":"10.1016\/bs.pmbts.2026.01.029_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuad039","article-title":"Faecalibacterium: a bacterial genus with promising human health applications","volume":"47","author":"Mart\u00edn","year":"2023","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"10.1016\/bs.pmbts.2026.01.029_bib13","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2575923","article-title":"Design and application of synthetic human gut microbial communities","volume":"17","author":"Kim","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/bs.pmbts.2026.01.029_bib14","doi-asserted-by":"crossref","first-page":"1632435","DOI":"10.3389\/fmicb.2025.1632435","article-title":"The human microbiome in clinical translation: from bench to bedside","volume":"16","author":"Bautista","year":"2025","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/bs.pmbts.2026.01.029_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12929-025-01207-w","article-title":"Molecular insights into the antimicrobial and cardiometabolic functions of Lactobacillus crispatus isolated from the reproductive tract microbiota of Indian women","volume":"33","author":"Mahajan","year":"2026","journal-title":"J Biomed Sci"}],"container-title":["Progress in Molecular Biology and Translational Science","Live Biotherapeutics: Advancing Microbial Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187711732600044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187711732600044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:31:38Z","timestamp":1791387098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187711732600044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443431906"],"references-count":15,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2026.01.029","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}